Respiratory Infections News

In 2014, the United Nations initiated the End TB Strategy, setting a goal of ending tuberculosis by 2035.

Among patients hospitalized with moderate COVID-19, those who received aspirin on the first day of hospitalization had a significantly lower risk for 28-day mortality than those who did not, according to a recent observational cohort study.

As of late February, just 64.5% of Americans were fully vaccinated against COVID-19, and less than half of eligible people had received a recommended booster dose.

Last month, The New York Times reported that the CDC has withheld some of the data it has collected on COVID-19 boosters and hospitalizations.

As a prior history major, I was drawn to infectious diseases by the patient stories, by the high value that the field placed on patients’ narratives and social contexts.

CDC data show that the omicron BA.2 subvariant of SARS-CoV-2 accounted for approximately 35% of COVID-19 cases in the United States during the week ending March 19, up from around 22% the week before.

Moderna said Wednesday that it will submit a request to the FDA “in the coming weeks” seeking authorization of its COVID-19 vaccine for children aged younger than 6 years.

Severe COVID-19 was associated with ophthalmological manifestations in more than one-third of patients who presented to a single center with the disease, according to a study published in Retina.

There was a 20% decline in reported cases of tuberculosis in the United States in 2020 compared with previous years, which was not a result of underreporting but did raise concerns that TB was underdiagnosed, researchers said.

In this video, Amesh A. Adalja, MD, a senior scholar in the Johns Hopkins Center for Health Security, describes his experiences during the first months of the COVID-19 pandemic in 2020.